Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do bacteria cause exacerbations of COPD?

J V Hirschmann1

  • 1Medical Service, Puget Sound VA Medical Center, University of Washington School of Medicine, Seattle, WA, USA. pepsi@u.washington.edu

Chest
|July 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charles Edward Smith: Coccidioidomycologist and public health leader.

Journal of medical biography·2020
Same author

The Discovery of Q Fever and Its Cause.

The American journal of the medical sciences·2019
Same author

Paul Beeson (1908-2006), Distinguished Physician.

Journal of medical biography·2018
Same author

From Squirrels to Biological Weapons: The Early History of Tularemia.

The American journal of the medical sciences·2018
Same author

Raynaud's phenomenon-Correction.

Journal of general internal medicine·2016
Same author

When antibiotics are unnecessary.

Dermatologic clinics·2008
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

Antibiotic therapy offers no significant benefit for most chronic obstructive pulmonary disease (COPD) exacerbations. Studies show bacterial infections are often absent or unchanged during COPD flare-ups, questioning the value of antibiotics.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Exacerbations of chronic obstructive pulmonary disease (COPD) are common and characterized by increased symptoms like dyspnea and cough.
  • The role of bacterial infections in triggering COPD exacerbations and the efficacy of antibiotic treatment remain subjects of debate.

Purpose of the Study:

  • To critically assess the evidence regarding bacterial infection's role in COPD exacerbations.
  • To evaluate the clinical benefit of antibiotic therapy for managing COPD exacerbations.

Main Methods:

  • Review of microbiological, serologic, and histologic studies on COPD exacerbations.
  • Analysis of randomized, placebo-controlled trials and meta-analyses of antibiotic therapy in COPD.

Related Experiment Videos

Main Results:

  • Bacterial pathogens (e.g., Streptococcus pneumoniae, Haemophilus influenzae) are absent in approximately 50% of exacerbations and do not increase in frequency or density.
  • Serologic studies and vaccine trials show limited evidence supporting bacterial involvement or benefit from antibiotics.
  • Histologic findings often show increased eosinophils, not neutrophils, and meta-analyses indicate no clinically significant advantage of antimicrobial therapy.

Conclusions:

  • Current evidence suggests bacterial infections are not the primary driver for many COPD exacerbations.
  • Antibiotic therapy provides no clear clinical advantage for mild COPD exacerbations and is likely not helpful for severe attacks, even when combined with corticosteroids.